&nbsp;

Dec 2025

Drug

anastrozole

Other Name(s): Arimidex®

Quick Link(s):

Dec 2025

Regimen

ACAL

Cancer Type:

Hematologic,

Leukemia - Chronic Lymphocytic (CLL)

Intent: Palliative

Funding:

Exceptional Access Program

acalabrutinib - For the treatment of adult patients with chronic lymphocytic leukemia (CLL), based on criteria

Drugs Used:

acalabrutinib

... Show more tags

Quick Link(s):

Regimen Monograph

Dec 2025

Drug

atezolizumab

Other Name(s): Tecentriq™

Quick Link(s):

Jul 2025

Drug

oxaliplatin

Quick Link(s):

Oct 2023

Guidelines and Advice

Organizational Guidance for the Care of Patients with Head and Neck Cancer in Ontario

Status: In-Review
ID: GL 5-3ORG
Version: 2

Apr 2019

Guidelines and Advice

Optimization of Surgical and Pathological Quality Performance in Radical Surgery for Colon and Rectal Cancer: Margins and Lymph Nodes

Status: Archived
ID: 17-4
Version: 2

Nov 2016

Regimen

ABVD

Cancer Type:

Hematologic,

Lymphoma - Hodgkin

Intent: Curative

Drugs Used:

Quick Link(s):

Regimen Monograph, Patient Info Sheet

Feb 2026

Regimen

ACAL

Cancer Type:

Hematologic,

Lymphoma - Non-Hodgkin's Low Grade

Intent: Palliative

Drugs Used:

acalabrutinib (Unfunded)

... Show more tags

Quick Link(s):

Regimen Monograph

Mar 2026

Regimen

ACALBEND+RITU; ACAL+RITU(MNT)

Cancer Type:

Hematologic,

Lymphoma - Non-Hodgkin's Low Grade

Intent: Palliative

Funding:

Exceptional Access Program

acalabrutinib - In Combination with Bendamustine and Rituximab for Mantle Cell Lymphoma, based on criteria

New Drug Funding Program

Rituximab (Biosimilar IV) and Rituximab SC in Combination with Chemotherapy - Indolent B-cell Lymphoma

New Drug Funding Program

Rituximab (Biosimilar IV) and Rituximab SC in Combination with Chemotherapy - Indolent B-cell Lymphoma

New Drug Funding Program

Rituximab (Biosimilar IV) and Rituximab SC - Maintenance Treatment - Lymphoma

New Drug Funding Program

Rituximab (Biosimilar IV) and Rituximab SC - Maintenance Treatment - Lymphoma

Drugs Used: